|
Re: Venting Friday!
|
8
|
Resverlogix Corp.
|
Feb 25, 2022 11:40AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
3
|
Zenith Epigenetics
|
Feb 25, 2022 11:50AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
4
|
Zenith Epigenetics
|
Feb 28, 2022 11:59AM
|
|
got this from Sarah yesterday..
|
11
|
Resverlogix Corp.
|
Mar 04, 2022 02:57PM
|
|
trying to making sense
|
8
|
Resverlogix Corp.
|
Mar 08, 2022 01:32PM
|
|
"FYI event tmr!" - from Sarah
|
2
|
Zenith Epigenetics
|
Mar 09, 2022 03:52PM
|
|
"FYI event tmr!" - from Sarah
|
7
|
Resverlogix Corp.
|
Mar 09, 2022 04:07PM
|
|
Re: "FYI event tmr!" - from Sarah
|
1
|
Zenith Epigenetics
|
Mar 09, 2022 04:09PM
|
|
Re: "FYI event tmr!" - from Sarah
|
5
|
Resverlogix Corp.
|
Mar 09, 2022 05:57PM
|
|
OTC Short interest up 0.88%/around 7k shrs to 767,637 as of the end of Feb
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 01:34PM
|
|
Re: OTC Short interest up 0.88%/around 7k shrs to 767,637 as of the end of Feb
|
1
|
Resverlogix Corp.
|
Mar 11, 2022 02:34PM
|
|
I wonder sometimes..
|
5
|
Resverlogix Corp.
|
Mar 16, 2022 11:41AM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
6
|
Resverlogix Corp.
|
Mar 18, 2022 09:47AM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
7
|
Resverlogix Corp.
|
Mar 18, 2022 12:08PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
6
|
Resverlogix Corp.
|
Mar 18, 2022 01:34PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
21
|
Resverlogix Corp.
|
Mar 19, 2022 01:56PM
|
|
what are the chances?
|
5
|
Resverlogix Corp.
|
Mar 24, 2022 01:50PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
5
|
Resverlogix Corp.
|
Mar 25, 2022 01:45PM
|
|
RV X OTC Short Interest Drops -5.002% from 767,105 to 729,105 as of March 15
|
2
|
Resverlogix Corp.
|
Mar 25, 2022 04:09PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 26, 2022 12:49PM
|
